drugset / Trial / NCT02239692

A Trial Comparing the PICOPREP Tailored Dosing Schedule to the PICOPREP Day-before Dosing Schedule for Colon Cleansing in Preparation for Colonoscopy

NCT02239692

Phase 3 Completed 204 enrolled Ferring Pharmaceuticals
RandomizedParallel-groupSingle-blind

Summary

This was a phase 3, randomised, assessor-blinded, multi-centre trial comparing the efficacy, safety and tolerability of a PICOPREP tailored dosing schedule to the PICOPREP day-before dosing schedule for colon cleansing in preparation for colonoscopy.

Timeline

Start
2014-11
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject PICOPREP Small molecule Oral

Indications

No indication recorded.